166 related articles for article (PubMed ID: 22717926)
1. The ability of high dose rosuvastatin to improve plaque composition in non-intervened coronary arteries: rationale and design of the Integrated Biomarker and Imaging Study-3 (IBIS-3).
Simsek C; Garcia-Garcia HM; van Geuns RJ; Magro M; Girasis C; van Mieghem N; Lenzen M; de Boer S; Regar E; van der Giessen W; Raichlen J; Duckers HJ; Zijlstra F; van der Steen T; Boersma E; Serruys PW;
EuroIntervention; 2012 Jun; 8(2):235-41. PubMed ID: 22717926
[TBL] [Abstract][Full Text] [Related]
2. Integrated Biomarker and Imaging Study 3 (IBIS-3) to assess the ability of rosuvastatin to decrease necrotic core in coronary arteries.
Oemrawsingh RM; Garcia-Garcia HM; van Geuns RJ; Lenzen MJ; Simsek C; de Boer SP; Van Mieghem NM; Regar E; de Jaegere PP; Akkerhuis KM; Ligthart JM; Zijlstra F; Serruys PW; Boersma E
EuroIntervention; 2016 Aug; 12(6):734-9. PubMed ID: 27542785
[TBL] [Abstract][Full Text] [Related]
3. Influence of high-dose lipid lowering treatment compared to low-dose lipid lowering treatment on plaque composition assessed by intravascular ultrasound virtual histology in patients with ST-segment elevation acute myocardial infarction: the VIRHISTAMI trial.
Egede R; Jensen LO; Hansen HS; Hansen KN; Junker A; Thayssen P
EuroIntervention; 2013 Feb; 8(10):1182-9. PubMed ID: 22987572
[TBL] [Abstract][Full Text] [Related]
4. Effect of statins on coronary bifurcation atherosclerosis: an intravascular ultrasound virtual histology study.
Shin ES; Garcia-Garcia HM; Okamura T; Serruys PW
Int J Cardiovasc Imaging; 2012 Oct; 28(7):1643-52. PubMed ID: 22179944
[TBL] [Abstract][Full Text] [Related]
5. Effects of statin treatments on coronary plaques assessed by volumetric virtual histology intravascular ultrasound analysis.
Hong MK; Park DW; Lee CW; Lee SW; Kim YH; Kang DH; Song JK; Kim JJ; Park SW; Park SJ
JACC Cardiovasc Interv; 2009 Jul; 2(7):679-88. PubMed ID: 19628193
[TBL] [Abstract][Full Text] [Related]
6. Comparison of effects of atorvastatin (20 mg) versus rosuvastatin (10 mg) therapy on mild coronary atherosclerotic plaques (from the ARTMAP trial).
Lee CW; Kang SJ; Ahn JM; Song HG; Lee JY; Kim WJ; Park DW; Lee SW; Kim YH; Park SW; Park SJ
Am J Cardiol; 2012 Jun; 109(12):1700-4. PubMed ID: 22440123
[TBL] [Abstract][Full Text] [Related]
7. Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography study.
Räber L; Taniwaki M; Zaugg S; Kelbæk H; Roffi M; Holmvang L; Noble S; Pedrazzini G; Moschovitis A; Lüscher TF; Matter CM; Serruys PW; Jüni P; Garcia-Garcia HM; Windecker S;
Eur Heart J; 2015 Feb; 36(8):490-500. PubMed ID: 25182248
[TBL] [Abstract][Full Text] [Related]
8. Early intervention with rosuvastatin decreases the lipid components of the plaque in acute coronary syndrome: analysis using integrated backscatter IVUS (ELAN study).
Otagiri K; Tsutsui H; Kumazaki S; Miyashita Y; Aizawa K; Koshikawa M; Kasai H; Izawa A; Tomita T; Koyama J; Ikeda U
Circ J; 2011; 75(3):633-41. PubMed ID: 21266787
[TBL] [Abstract][Full Text] [Related]
9. Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: a high-resolution magnetic resonance imaging trial.
Underhill HR; Yuan C; Zhao XQ; Kraiss LW; Parker DL; Saam T; Chu B; Takaya N; Liu F; Polissar NL; Neradilek B; Raichlen JS; Cain VA; Waterton JC; Hamar W; Hatsukami TS
Am Heart J; 2008 Mar; 155(3):584.e1-8. PubMed ID: 18294500
[TBL] [Abstract][Full Text] [Related]
10. [Effects of domestic rosuvastatin on coronary plaque in patients with mild-to-moderate coronary artery stenosis as evaluated by virtual histology-intravascular ultrasound].
Yang HB; Zhao XY; Zhao YT; Zhang JY; Li L
Zhonghua Yi Xue Za Zhi; 2012 Jun; 92(22):1550-2. PubMed ID: 22944060
[TBL] [Abstract][Full Text] [Related]
11. Change in near-infrared spectroscopy of a coronary artery after 1-year treatment with high dose rosuvastatin.
Simsek C; van Geuns RJ; Magro M; Boersma E; Garcia-Garcia HM; Serruys PW
Int J Cardiol; 2012 Jun; 157(3):e54-6. PubMed ID: 22000422
[No Abstract] [Full Text] [Related]
12. Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in female patients with non-ST-segment elevation acute coronary syndrome.
Gao Y; Jia ZM; Sun YJ; Zhang ZH; Ren LN; Qi GX
Chin Med J (Engl); 2012 Jul; 125(13):2250-4. PubMed ID: 22882843
[TBL] [Abstract][Full Text] [Related]
13. Rationale and design for a study using intravascular ultrasound to evaluate effects of rosuvastatin on coronary artery atheroma in Japanese subjects: COSMOS study (Coronary Atherosclerosis Study Measuring Effects of Rosuvastatin Using Intravascular Ultrasound in Japanese Subjects).
Takayama T; Hiro T; Yamagishi M; Daida H; Saito S; Yamaguchi T; Matsuzaki M
Circ J; 2007 Feb; 71(2):271-5. PubMed ID: 17251680
[TBL] [Abstract][Full Text] [Related]
14. Impact of baseline plaque components on plaque progression in nonintervened coronary segments in patients with angina pectoris on rosuvastatin 10 mg/day.
Hong YJ; Jeong MH; Choi YH; Ma EH; Ko JS; Lee MG; Park KH; Sim DS; Yoon NS; Youn HJ; Kim KH; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
Am J Cardiol; 2010 Nov; 106(9):1241-7. PubMed ID: 21029819
[TBL] [Abstract][Full Text] [Related]
15. [Rosuvastatin improves myocardial function and arteriosclerosis plaque in patients with ST-segment elevation after acute myocardial infarction and percutaneous coronary intervention].
Lin ZP; Shu PC; Liao ZJ; Wang XQ; Liu Q
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Oct; 31(10):1789-91. PubMed ID: 22027793
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of achieving very low low-density lipoprotein cholesterol levels with rosuvastatin 40 mg daily (from the ASTEROID Study).
Wiviott SD; Mohanavelu S; Raichlen JS; Cain VA; Nissen SE; Libby P
Am J Cardiol; 2009 Jul; 104(1):29-35. PubMed ID: 19576317
[TBL] [Abstract][Full Text] [Related]
17. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
Strandberg TE; Feely J; Sigurdsson EL;
Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
[TBL] [Abstract][Full Text] [Related]
18. Myopathy caused by a combination rosuvastatin and fenofibrate.
Dedhia V; Munsi SC
J Assoc Physicians India; 2007 Feb; 55():152-3. PubMed ID: 17571748
[No Abstract] [Full Text] [Related]
19. One-year efficacy and safety of rosuvastatin + fenofibric acid combination therapy in patients with mixed dyslipidemia: evaluation of dose response.
Ferdinand KC; Davidson MH; Kelly MT; Setze CM
Am J Cardiovasc Drugs; 2012 Apr; 12(2):117-25. PubMed ID: 22263674
[TBL] [Abstract][Full Text] [Related]
20. Effects of the PCSK9 antibody alirocumab on coronary atherosclerosis in patients with acute myocardial infarction: a serial, multivessel, intravascular ultrasound, near-infrared spectroscopy and optical coherence tomography imaging study-Rationale and design of the PACMAN-AMI trial.
Zanchin C; Koskinas KC; Ueki Y; Losdat S; Häner JD; Bär S; Otsuka T; Inderkum A; Jensen MRJ; Lonborg J; Fahrni G; Ondracek AS; Daemen J; van Geuns RJ; Iglesias JF; Matter CM; Spirk D; Juni P; Mach F; Heg D; Engstrom T; Lang I; Windecker S; Räber L
Am Heart J; 2021 Aug; 238():33-44. PubMed ID: 33951415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
